Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Polyganics B.V., — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

69 daysmedian FDA review time
110 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K141816HEMOPOREPolyganics B.V.,2014-10-231080
K141423NASOPORE-FDPolyganics B.V.,2014-08-07690
K112267NEUROLAC(R) NERVE GUIDEPolyganics B.V.,2011-10-20730
K070715NASOPORE EARPolyganics B.V.,2007-05-075413
K062540NASOPORE EAR, MODELS ND04, ND05Polyganics B.V.,2006-10-18490
K052099NASOPORE NASAL DRESSING, MODEL NDOX-YYY/ZZPolyganics B.V.,2005-11-211100
K050573NEUROLAC NERVE GUIDEPolyganics B.V.,2005-05-04580
K042811VIVOSORB SHEET, MODEL FS01Polyganics B.V.,2004-11-08270
K032115NEUROLAC NERVE GUIDE MODELS NG01-15/03, NG01-020/03, NG01 02Polyganics B.V.,2003-10-10930

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda